Proteasome subunit LMP2 is required for matrix metalloproteinase-2 and -9 expression and activities in human invasive extravillous trophoblast cell line

Journal of Cellular Physiology

Volumn 206, Issue 3, 2006, Pages 616-623

  Wang, Hong Xing ^a,b   Wang, Hong Mei ^a   Lin, Hai Yan ^a,b   Yang, Qing ^a,b   Zhang, Heng ^a,b   Tsang, Benjamin K ^c   Zhu, Cheng ^a  

^a INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEASOME; PROTEIN LMP2; PROTEIN P50; PROTEIN SUBUNIT; SMALL INTERFERING RNA; SYNAPTOTAGMIN; UBIQUITIN PROTEASOME; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; CELL LINE; CELL NUCLEUS; CELL STRAIN HTR8; CELL STRAIN SVNEO; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBUNIT; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLASMID; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REGULATORY MECHANISM; TROPHOBLAST;

CELL LINE; CELL LINE, TUMOR; CYSTEINE ENDOPEPTIDASES; HUMANS; I-KAPPA B PROTEINS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NF-KAPPA B; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION; TROPHOBLASTS;

EID: 31944432777     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20508     Document Type: Article

References (43)

1. Allan JA, Docherty AJ, Barker PJ, Huskisson NS, Reynolds JJ, Murphy G. 1995. Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem J 309:299-306.
2. Baumeister W, Walz J, Zuhl F, Seemuller E. 1998. The proteasome: Paradigm of a self-compartmentalizing protease. Cell 92:367-380.
3. Brooks P, Murray RZ, Mason GG, Hendil KB, Rivett AJ. 2000. Association of immunoproteasomes with the endoplasmic reticulum. Biochem J 352:611-615.
4. Brummelkamp TR, Bernards R, Agami R. 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553.
5. Carson DD, Bagchi I, Dey SK, Enders AC, Fazleabas AT, Lessey BA, Yoshinaga K 2000. Embryo implantation. Dev Biol 223:217-237.
6. Chen LF, Greene WC. 2004. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5:392-401.
7. Chen Z, Hagler J, Palombella VJ, Melandri F, Scherer D, Ballard D, Maniatis T. 1995. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev 9:1586-1597.
8. Ciechanover A. 1998. The ubiquitin-proteasome pathway: On protein death and cell life. EMBO J 17:7151-7160.
9. Craiu A, Gaczynska M, Akopian T, Gramm CF, Fenteany G, Goldberg AL, Rock KL. 1997. Lactacystin and clasto-lactacystin β-lactone modify multiple proteasome subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J Biol Chem 272: 13437-13445.
10. Cross JC, Werb Z, Fisher SJ. 1994. Implantation and the placenta: Key pieces of the development puzzle. Science 266:1508-1518.
11. Denti MA, Rosa A, Sthandier O, De Angelis FG, Bozzoni I. 2004. A new vector, based on the PolII promoter of the Ul snRNA gene, for the expression of siRNAs in mammalian cells. Mol Ther 10:191-199.
12. Gaczynska M, Goldberg AL, Tanaka K, Hendil KB, Rock KL. 1996. Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-γ-induced subunits LMP2 and LMP7. J Biol Chem 271:17275-17280.
13. Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, Bartunik HD, Huber R. 1997. Structure of 20S proteasome from yeast at 2.4 Å resolution. Nature 386:463-471.
14. Han YP, Tuan TL, Wu H, Hughes M, Garner WL. 2001. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci 114:131-139.
15. Hannon GJ. 2002. RNA interference. Nature 418:244-251.
16. Hayashi T, Faustman D. 2000. Essential role of human leukocyte antigen-encoded proteasome subunits in NF-kappaB activation and prevention of tumor necrosis factor-alpha-induced apoptosis. J Biol Chem 275:5238-5247.
17. Hayashi T, Faustman D. 2002. Development of spontaneous uterine tumors in low molecular mass polypeptide-2 knockout mice. Cancer Res 62:24-27.
18. Hayden MS, Ghosh S. 2004. Signaling to NF-kappaB. Genes Dev 18:2195-2224.
19. Hernandez-Barrantes S, Toth M, Bernardo MM, Yurkova M, Gervasi DC, Raz Y, Sang QA, Fridman R. 2000. Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J Biol Chem 275:12080-12089.
20. Hozumi A, Nishimura Y, Nishiuma T, Kotani Y, Yokoyama M. 2001. Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway. Am J Physiol Lung Cell Mol Physiol 281:L1444-L1452.
21. Huhtala P, Tuuttila A, Chow LT, Lohi J, Keski-Oja J, Tryggvason K. 1991. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J Biol Chem 266:16485-16490.
22. Ikebe T, Takeuchi H, Jimi E, Beppu M, Shinohara M, Shirasuna K. 1998. Involvement of proteasomes in migration and matrix metalloproteinase-9 production of oral squamous cell carcinoma. Int J Cancer 77:578-585.
23. Kuchelkorn U, Frentzel S, Kraft R, Kostka S, Groettrup M, Kloetzel PM. 1995. Incorporation of major histocompatibility complex-encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-γ. Eur J Immunol 25:2605-2611.
24. Lin L, DeMartino GN, Greene WC. 1998. Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell 92:819-828.
25. Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J. 1995. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 270:14255-14258.
26. Lowe J, Stock D, Jap B, Zwickl P, Baumeister W, Huber R. 1995. Crystal structure of the 20S proteasome from the archacon T. acidophilum at 3.4 Å resolution. Science 268:533-539.
27. McCawley LJ, Matrisian LM. 2001. Matrix metalloproteinases: They're not just for matrix anymore! Curr Opin Cell Biol 13:534-540.
28. Nagase H, Woessner JF, Jr. 1999. Matrix metalloproteinases. J Biol Chem 274:21491-21494.
29. Polette M, Nawrocki B, Pintiaux A, Massenat C, Maquoi E, Volders L, Schaaps JP, Birembaut P, Foidart JM. 1994. Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium. Lab Invest 71:838-846.
30. Reits EA, Benham AM, Plougaste B, Neefjes J, Trowsdale J. 1997. Dynamics of proteasome distribution in living cells. EMBO J 16:6087-6094.
31. Schmidtke G, Kraft R, Kostka S, Henklein P, Frommel C, Lowe J, Huber R, Kloetzel PM, Schmidt M. 1996. Analysis of mammalian 20S proteasome biogenesis: The maturation of β-subunits is an ordered two-step mechanism involving autocatalysis. EMBO J 15:6887-6898.
32. Sears C, Olesen J, Rubin D, Finley D, Maniatis T. 1998. NF-kappa B p105 processing via the ubiquitin-proteasome pathway. J Biol Chem 273:1409-1419.
33. Shah BH, Catt KJ. 2004. Matrix metalloproteinases in reproductive endocrinology. Trends Endocrinol Metab 15:47-49.
34. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. 1995. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270:5331-5338
35. Sui G, Soohoo C, Affar el B, Gay F, Shi Y, Forrester WC, Shi Y. 2002. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA 99:5515-5520.
36. Ustrell V, Pratt G, Rechsteiner M. 1995. Effects of interferon-γ and major histocompatibility complex- encoded subunits on peptidase activities of human multicatalytic proteases. Proc Natl Acad Sci USA 92:584-588.
37. Voges D, Zwickl P, Baumeister W. 1999. The 26S proteasome: A molecular machine designed for controlled proteolysis. Annu Rev Biochem 68:1015-1068.
38. Wang HM, Zhang X, Qian D, Lin HY, Li QL, Liu DL, Liu GY, Yu XD, Zhu C. 2004a. Effect of ubiquitin-proteasome pathway on mouse blastocyst implantation and expression of matrix metalloproteinases-2 and-9. Biol Reprod 70:481-487.
39. Wang HX, Wang HM, Li QL, Lin HY, Qian D, Zhu C. 2004b. Expression of proteasome subunits low molecular mass polypeptide (LMP) 2 and LMP7 in the endometrium and placenta of rhesus monkey (Macaca mulatta) during early pregnancy. Biol Reprod 71:1317-1324.
40. Woo JH, Park JW, Lee SH, Kim YH, Lee IK, Gabrielson E, Lee SH, Lee HJ, Kho YH, Kwon TK. 2003. Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting nuclear factor kappa B transcriptional activity. Cancer Res 63:3430-3434.
41. Xie Z, Singh M, Singh K. 2004. Differential regulation of matrix metalloproteinase-2 and-9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta. J Biol Chem 279:39513-39519.
42. Xu P, Alfaidy N, Challis JR. 2002. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in human placenta and fetal membranes in relation to preterm and term labor. J Clin Endocrinol Metab 87:1353-1361.
43. Yamamoto Y, Gaynor RB. 2004. IkappaB kinases: Key regulators of the NF-kappaB pathway. Trends Biochem Sci 29:72-79.